B Braun had claimed that intravenous catheters sold by Poly Medicure were infringing its patents. But, the EPO ruled in favour of Poly Medicure and revoked B Braun’s patent, marking the third and final time the company has had a patent relating to its intravenous catheters revoked.
In a statement, Himanshu Baid, managing director of Poly Medicure said that the ruling would allow the company to “freely operate in the European market”.
Rishi Baid, executive director of Poly Medicure, said B Braun had attempted to broaden the patent and claim much more than the patent actually covered.
Poly Medicure’s catheters offer a needle guard that protects doctors and nursing staff when withdrawing the needle from a patient's arm.